FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease5/11/23 12:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
Antipsychotic Polypharmacy at Higher Doses Does Not Increase Hospitalization Risk, Study Finds3/23/23 12:00 AM
Breast Cancer in Women With Severe Mental Illness Often Undertreated, Review Suggests3/21/23 12:00 AM
